| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | NOVARTIS AG | May 22, 2026 | |
| Buy | Novartis AG Common Stock | Mar 31, 2026 | |
| Buy | Novartis AG Common Stock | Mar 30, 2026 | |
| Sell | Novartis AG Common Stock | Oct 31, 2025 | |
| Buy | Novartis AG Common Stock | Oct 30, 2025 | |
| Sell | Novartis AG Common Stock | Oct 30, 2025 | |
| Sell | Novartis AG Common Stock | Sep 25, 2025 | |
| Buy | Novartis AG Common Stock | Sep 11, 2025 | |
| Sell | Novartis AG Common Stock | Jul 22, 2025 | |
| Buy | Novartis AG Common Stock | Jun 17, 2025 |
This page tracks congressional stock trading activity in Novartis AG (NVS) in the Healthcare sector. Disclosed Capitol has indexed 142 disclosed congressional trades involving NVS. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 142 disclosed congressional trades in Novartis AG (NVS) — 67:26 sell-heavy ratio — led by Donald Sternoff Beyer (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| May 22, 2026 | Michael McCaul | R | Sell | $100,001 - $250,000 |
| Mar 31, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Mar 30, 2026 | Alan Armstrong | R | Buy | $15,001 - $50,000 |
| Oct 31, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Oct 30, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
| Oct 30, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Sep 25, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Sep 11, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
| Jul 22, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Jun 17, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
Across the 142 disclosed congressional trades in Novartis AG (NVS), members of Congress have reported 26 buys and 67 sells. The average 30-day alpha vs. the S&P 500 is -0.04%.